As any healthcare founder knows, it can be difficult to get into a room with the executives making purchase decisions for payors and providers—so we’re bringing the executives to you.
This episode features interviews with payor and provider leaders about what they’re seeing and how they’re thinking about AI. Guided by Julie Yoo, general partner, and Jay Rughani, investment partner at a16z Bio + Health, you'll hear from the executives about how they're utilizing AI, the KPIs they use to gauge effectiveness, and what they consider a good partnership.
Julie and Jay also authored an in-depth guide to commercializing AI in healthcare based on these interviews, available here. All of our go-to-market playbooks are available on our Digital Health Builders page.
AI and Actionable Insights for Drug Development with Daphne Koller
Journal Club: Remodeling Oncogenic Transcriptomes with Ben Cravatt and Gene Yeo
Health System Partnerships with Tommy Ibrahim
From the Archives: The Art & Science of Biology's Future with Jennifer Doudna
The Power of a Platform Company with Josh Mandel-Brehm
Culture and Company Building with Sam Corcos
Payments & Payors: Fintech's Role with Kurt Adams
American Optimism with Joe Lonsdale
Going to Market in Healthcare: B2C2B
Advancing the Field of Immunotherapeutics
Healthspan, Lifespan, and the Biology of Aging
Payors and Providers Post-Pandemic
Using AI to Take Bio Farther
Expert AI as a Healthcare Superpower
Cultivated Meat: Challenges, Opportunities, Future
AI is Here. Now What?
Regulatory Trends in Telehealth
Demystifying DC: Opportunities for Collaboration
The Consolidated Drug Channel and Cash-Pay Drugs
Bio x Games: Is a Fun, Therapeutic Game Possible?
Create your
podcast in
minutes
It is Free